Evaluation of the immune system during HIV infection and AIDS: T cell subsets, November 3, 1988, San FranciscoFAHEY, John L.Clinical immunology and immunopathology (Print). 1989, Vol 52, Num 1, issn 0090-1229, 1-103 [103 p.]Conference Proceedings

Viral safety and evaluation of viral clearance from biopharmaceutical products. SymposiumBROWN, Fred; LUBINIECKI, A.Developments in biological standardization. 1996, Num 88, issn 0301-5149, 349 p.Conference Proceedings

Contamination of genetically engineered Chinese hamster ovary cellsBURSTYN, D. G.Developments in biological standardization. 1996, Num 88, pp 199-203, issn 0301-5149Conference Paper

Follow-up studies of hepatitis C association with an intravenous immunoglobulinYU, M. W.Developments in biological standardization. 1996, Num 88, pp 215-216, issn 0301-5149Conference Paper

Multi-use manufacturing facilitiesGARFINKLE, B. D.Developments in biological standardization. 1996, Num 88, issn 0301-5149, p. 131Conference Paper

Viral safety of biological products and the concept of validationHORAUD, F.Developments in biological standardization. 1996, Num 88, pp 19-24, issn 0301-5149Conference Paper

Adventitious agents from animal-derived raw materials: A method of risk assessmentFOSTER, L. G.Developments in biological standardization. 1996, Num 88, pp 283-290, issn 0301-5149Conference Paper

Issues realted to harmonization of testing requirements for viral safetyHAYAKAWA, T.Developments in biological standardization. 1996, Num 88, pp 15-18, issn 0301-5149Conference Paper

Sourcing pharmaceutical, biological and medical components from livestock in the United StatesDETWILER, L. A.Developments in biological standardization. 1996, Num 88, pp 243-245, issn 0301-5149Conference Paper

Strategy for adventitious agent assaysROBERTSON, J. S.Developments in biological standardization. 1996, Num 88, pp 37-40, issn 0301-5149Conference Paper

Viral safety and evaluation of viral clearance from biopharmaceutical products : Goals of the meetingSEAMON, K.Developments in biological standardization. 1996, Num 88, pp 3-4, issn 0301-5149Conference Paper

Zoonotic agent consideration in xenotransplants: Introductory comments for breakout session F : Adventitious agents from animal-derived raw materials and production systemsHONSTEAD, J. P.Developments in biological standardization. 1996, Num 88, pp 235-236, issn 0301-5149Conference Paper

Analysis of risk to biomedical products developed from animal sources (with special emphasis on the spongiform encephalopathy agents, scrapie and BSE)ROHWER, R. G.Developments in biological standardization. 1996, Num 88, pp 247-256, issn 0301-5149Conference Paper

Experience with viral contamination in cell cultureGARNICK, R. L.Developments in biological standardization. 1996, Num 88, pp 49-56, issn 0301-5149Conference Paper

Key points from Nettleton and Rweyemamu (1980) : Association of calf serum with parvovirus infectionHUGHES, B.Developments in biological standardization. 1996, Num 88, pp 205-206, issn 0301-5149Conference Paper

Evolving Scientific and Regulatory Perspectives on Cell Substrates for Vaccine DevelopmentBROWN, Fred; LEWIS, Andrew; KRAUSE, Philip et al.Developments in biologicals. 2001, Vol 106, issn 1424-6074, 555 p.Conference Proceedings

Experimental experience with virus validation studiesWILLKOMMEN, H.Developments in biological standardization. 1996, Num 88, pp 317-318, issn 0301-5149Conference Paper

Introduction to the issues : Assays for screening contaminationHEWLETT, I. K.Developments in biological standardization. 1996, Num 88, pp 33-35, issn 0301-5149Conference Paper

Issues of biological assays for viral vaccinesLEE, C. K.Developments in biological standardization. 1996, Num 88, pp 41-47, issn 0301-5149Conference Paper

Mammalian cells and their contaminantsMINOR, P. D.Developments in biological standardization. 1996, Num 88, pp 25-29, issn 0301-5149Conference Paper

Process considerations for minimizing virus transmissions from primary porcine tissuesGIL, P. J.Developments in biological standardization. 1996, Num 88, pp 277-281, issn 0301-5149Conference Paper

Transmissible encephalopathies and biopharmaceutical productionROBINSON, M. M.Developments in biological standardization. 1996, Num 88, pp 237-241, issn 0301-5149Conference Paper

Risk assessment and limitations of evaluation studiesLÖWER, J.Developments in biological standardization. 1996, Num 88, issn 0301-5149, p. 109Conference Paper

Survey of manufacturers and developers of cell culture-derived products for evidence of adventitious contaminationLUBINIECKI, A. S.Developments in biological standardization. 1996, Num 88, pp 195-197, issn 0301-5149Conference Paper

The safety of biopharmaceutical products: A personal viewpointFINTER, N. B.Developments in biological standardization. 1996, Num 88, pp 133-137, issn 0301-5149Conference Paper